Byron Finn - SunLink Health President of SunLink ScriptsRx, LLC.
| SSY Stock | USD 0.86 0.11 14.67% |
President
Mr. Byron D. Finn, CPA, is a President of SunLink ScriptsRx, LLC. of the Company. Mr. Finn was President of Byron D. Finn, CPA, PC, which provided accounting, financial consulting, and litigation support services for clients, including numerous healthcare clients. His experience also includes various positions with The CocaCola Company, where he served in a number of financialrelated positions and in connection with special projects, and he was previously employed by Ernst Young since 2010.
| Age | 68 |
| Tenure | 14 years |
| Professional Marks | CPA |
| Address | 900 Circle 75 Parkway, Atlanta, GA, United States, 30339 |
| Phone | 770 933 7000 |
| Web | https://www.sunlinkhealth.com |
SunLink Health Management Efficiency
The company has Return on Asset of (0.0954) % which means that on every $100 spent on assets, it lost $0.0954. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1476) %, meaning that it generated no profit with money invested by stockholders. SunLink Health's management efficiency ratios could be used to measure how well SunLink Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, SunLink Health's Return On Tangible Assets are fairly stable compared to the past year. Return On Assets is likely to rise to 0.01 in 2024, despite the fact that Return On Capital Employed is likely to grow to (0.04). At this time, SunLink Health's Total Assets are fairly stable compared to the past year. Total Current Assets is likely to rise to about 24.9 M in 2024, whereas Non Current Assets Total are likely to drop slightly above 4.7 M in 2024.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Paul Marchetti | Elevance Health | N/A | |
| John III | Humana Inc | N/A | |
| Mark Brooks | Centene Corp | 54 | |
| George II | Humana Inc | 55 | |
| Andrew Asher | Centene Corp | 55 | |
| Keith Williamson | Centene Corp | 66 | |
| Thomas Roos | UnitedHealth Group Incorporated | 51 | |
| Jeffrey Schwaneke | Centene Corp | 44 | |
| Eric Palmer | Cigna Corp | 48 | |
| Nicole Jones | Cigna Corp | 53 | |
| Cynthia Zipperle | Humana Inc | 58 | |
| Everett Neville | Cigna Corp | 59 | |
| Kenneth Fasola | Centene Corp | 64 | |
| Bethanie Stein | Humana Inc | N/A | |
| James MBA | Humana Inc | 53 | |
| William Fleming | Humana Inc | 53 | |
| Mark Boxer | Cigna Corp | 59 | |
| Jason Sadler | Cigna Corp | 55 | |
| H Sanders | Centene Corp | N/A | |
| Alan Wheatley | Humana Inc | 51 | |
| Noelle Eder | Cigna Corp | 54 | |
Management Performance
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0954 |
SunLink Health Systems Leadership Team
Elected by the shareholders, the SunLink Health's board of directors comprises two types of representatives: SunLink Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of SunLink. The board's role is to monitor SunLink Health's management team and ensure that shareholders' interests are well served. SunLink Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, SunLink Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| C Ford, Independent Director | ||
| James Mulligan, General Emeritus | ||
| Sheila Brockman, Vice President | ||
| Mark Stockslager, Chief Financial Officer, Principal Accounting Officer | ||
| Theresa Mota, Secretary | ||
| Byron CPA, LLC ScriptsRX | ||
| Gene Burleson, Independent Director | ||
| Karen Brenner, Independent Director | ||
| Howard Turner, Independent Director | ||
| Steven Baileys, Independent Director | ||
| Christopher Mills, Independent Director | ||
| Byron Finn, President of SunLink ScriptsRx, LLC. | ||
| Robert Thornton, Executive Chairman, CEO and President and Chairman of Executive Committee | ||
| Neal Miller, Inc Technology |
SunLink Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is SunLink Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.15 | ||||
| Return On Asset | -0.0954 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | (0.15) % | ||||
| Current Valuation | (988.73 K) | ||||
| Shares Outstanding | 7.04 M | ||||
| Shares Owned By Insiders | 26.60 % | ||||
| Shares Owned By Institutions | 13.44 % | ||||
| Number Of Shares Shorted | 17.88 K | ||||
| Price To Earning | 3.06 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for SunLink Stock Analysis
When running SunLink Health's price analysis, check to measure SunLink Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SunLink Health is operating at the current time. Most of SunLink Health's value examination focuses on studying past and present price action to predict the probability of SunLink Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SunLink Health's price. Additionally, you may evaluate how the addition of SunLink Health to your portfolios can decrease your overall portfolio volatility.